Mutations of the genes affecting chromatin remodeling and cell differentiation such as NPM1, DNMT3A, and TET2 are frequently detected not only in AML but also in other types of cancer including solid tumors [45]. This evidence concerns the gene DNMT3A and acute myeloid leukemia.